<?xml version="1.0" encoding="UTF-8"?>
<TED_EXPORT xmlns:xlink="http://www.w3.org/1999/xlink"
            xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
            xmlns="ted/R2.0.9.S02/publication"
            xmlns:n2016="ted/2016/nuts"
            xsi:schemaLocation="ted/R2.0.9.S02/publication TED_EXPORT.xsd"
            VERSION="R2.0.9.S02.E01"
            DOC_ID="112984-2018"
            EDITION="2018051">
   <TECHNICAL_SECTION>
      <RECEPTION_ID>18-114580-001</RECEPTION_ID>
      <DELETION_DATE>20180413</DELETION_DATE>
      <FORM_LG_LIST>EN </FORM_LG_LIST>
      <COMMENTS>From Convertor</COMMENTS>
   </TECHNICAL_SECTION>
   <LINKS_SECTION>
      <XML_SCHEMA_DEFINITION_LINK xlink:type="simple"
                                  xlink:href="http://ted.europa.eu"
                                  xlink:title="TED WEBSITE"/>
      <OFFICIAL_FORMS_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/>
      <FORMS_LABELS_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/>
      <ORIGINAL_CPV_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/>
      <ORIGINAL_NUTS_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/>
   </LINKS_SECTION>
   <CODED_DATA_SECTION>
      <REF_OJS>
         <COLL_OJ>S</COLL_OJ>
         <NO_OJ>51</NO_OJ>
         <DATE_PUB>20180314</DATE_PUB>
      </REF_OJS>
      <NOTICE_DATA>
         <NO_DOC_OJS>2018/S 051-112984</NO_DOC_OJS>
         <URI_LIST>
            <URI_DOC LG="EN">http://ted.europa.eu/udl?uri=TED:NOTICE:112984-2018:TEXT:EN:HTML</URI_DOC>
         </URI_LIST>
         <LG_ORIG>EN</LG_ORIG>
         <ISO_COUNTRY VALUE="DE"/>
         <IA_URL_GENERAL>www.helmholtz-muenchen.de</IA_URL_GENERAL>
         <ORIGINAL_CPV CODE="33650000">General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents</ORIGINAL_CPV>
         <n2016:PERFORMANCE_NUTS CODE="DE21H">München, Landkreis</n2016:PERFORMANCE_NUTS>
         <n2016:CA_CE_NUTS CODE="DE21H">München, Landkreis</n2016:CA_CE_NUTS>
      </NOTICE_DATA>
      <CODIF_DATA>
         <DS_DATE_DISPATCH>20180312</DS_DATE_DISPATCH>
         <DT_DATE_FOR_SUBMISSION>20180413 12:00</DT_DATE_FOR_SUBMISSION>
         <AA_AUTHORITY_TYPE CODE="6">Body governed by public law</AA_AUTHORITY_TYPE>
         <TD_DOCUMENT_TYPE CODE="A">Prior information notice with call for competition</TD_DOCUMENT_TYPE>
         <NC_CONTRACT_NATURE CODE="4">Services</NC_CONTRACT_NATURE>
         <PR_PROC CODE="B">Competitive procedure with negotiation</PR_PROC>
         <RP_REGULATION CODE="5">European Union, with participation by GPA countries</RP_REGULATION>
         <TY_TYPE_BID CODE="1">Submission for all lots</TY_TYPE_BID>
         <AC_AWARD_CRIT CODE="Z">Not specified</AC_AWARD_CRIT>
         <MA_MAIN_ACTIVITIES CODE="8">Other</MA_MAIN_ACTIVITIES>
         <HEADING>01C01</HEADING>
         <INITIATOR>01</INITIATOR>
         <DIRECTIVE VALUE="2014/24/EU"/>
      </CODIF_DATA>
   </CODED_DATA_SECTION>
   <TRANSLATION_SECTION>
      <ML_TITLES>
         <ML_TI_DOC LG="BG">
            <TI_CY>Гepмaния</TI_CY>
            <TI_TOWN>Neuherberg</TI_TOWN>
            <TI_TEXT>
               <P>Общи противовъзпалителни средства за системна употреба, ваксини, антинеопласти и имуномодулатори</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="CS">
            <TI_CY>Německo</TI_CY>
            <TI_TOWN>Neuherberg</TI_TOWN>
            <TI_TEXT>
               <P>Antiinfektiva pro systémové užití, očkovací látky, antineoplastika a imunomodulátory</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="DA">
            <TI_CY>Tyskland</TI_CY>
            <TI_TOWN>Neuherberg</TI_TOWN>
            <TI_TEXT>
               <P>Antiinfektive midler til systemisk brug, vacciner, cytostatike/cytotoxiske midler samt immunmodulerende midler</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="DE">
            <TI_CY>Deutschland</TI_CY>
            <TI_TOWN>Neuherberg</TI_TOWN>
            <TI_TEXT>
               <P>Antiinfektiva zur systemischen Anwendung, Impfstoffe, Antineoplastika und Immunmodulatoren</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="EL">
            <TI_CY>Γερμανία</TI_CY>
            <TI_TOWN>Neuherberg</TI_TOWN>
            <TI_TEXT>
               <P>Φάρμακα κατά των λοιμώξεων συστηματικής χρήσης, εμβόλια, αντινεοπλασματικά και ανοσορρυθμιστικά φάρμακα</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="EN">
            <TI_CY>Germany</TI_CY>
            <TI_TOWN>Neuherberg</TI_TOWN>
            <TI_TEXT>
               <P>General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="ES">
            <TI_CY>Alemania</TI_CY>
            <TI_TOWN>Neuherberg</TI_TOWN>
            <TI_TEXT>
               <P>Antiinfecciosos generales para uso sistémico, vacunas, antineoplásicos e inmunomoduladores</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="ET">
            <TI_CY>Saksamaa</TI_CY>
            <TI_TOWN>Neuherberg</TI_TOWN>
            <TI_TEXT>
               <P>Üldised infektsioonivastased ained süsteemseks kasutamiseks, vaktsiinid, antineoplastilised ja immuunmoduleerivad ained</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="FI">
            <TI_CY>Saksa</TI_CY>
            <TI_TOWN>Neuherberg</TI_TOWN>
            <TI_TEXT>
               <P>Systeemisesti vaikuttavat infektiolääkkeet, rokotteet sekä syöpälääkkeet ja immunomodulantit</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="FR">
            <TI_CY>Allemagne</TI_CY>
            <TI_TOWN>Neuherberg</TI_TOWN>
            <TI_TEXT>
               <P>Anti-infectieux généraux à usage systémique, vaccins, antinéoplasiques et immunomodulateurs</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="GA">
            <TI_CY>Ghearmáin, an</TI_CY>
            <TI_TOWN>Neuherberg</TI_TOWN>
            <TI_TEXT>
               <P>General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="HR">
            <TI_CY>Njemačka</TI_CY>
            <TI_TOWN>Neuherberg</TI_TOWN>
            <TI_TEXT>
               <P>Opća protuupalna sredstva za sustavno liječenje, cjepiva, antineoplastična sredstva i imunomodulatori</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="HU">
            <TI_CY>Németország</TI_CY>
            <TI_TOWN>Neuherberg</TI_TOWN>
            <TI_TEXT>
               <P>Általános fertőzésellenes szerek szisztémás használatra, vakcinák, daganatellenes és immunmodulátor szerek</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="IT">
            <TI_CY>Germania</TI_CY>
            <TI_TOWN>Neuherberg</TI_TOWN>
            <TI_TEXT>
               <P>Antinfettivi generali per uso sistemico, vaccini, agenti antineoplastici e immunomodulatori</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="LT">
            <TI_CY>Vokietija, VFR</TI_CY>
            <TI_TOWN>Neuherberg</TI_TOWN>
            <TI_TEXT>
               <P>Sistemiškai veikiantys priešinfekciniai vaistai, vakcinos, antinavikiniai vaistai ir imunomoduliatoriai</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="LV">
            <TI_CY>Vācija</TI_CY>
            <TI_TOWN>Neuherberg</TI_TOWN>
            <TI_TEXT>
               <P>Vispārēji pretinfekcijas līdzekļi sistēmiskai lietošanai, vakcīnas, antineoplastiskie līdzekļi un imūnmodulatori</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="MT">
            <TI_CY>il-Ġermanja</TI_CY>
            <TI_TOWN>Neuherberg</TI_TOWN>
            <TI_TEXT>
               <P>Anti-infettivi ġenerali għall-użu sistematiku, vaċċini, antineoplastika u aġenti immunomodulaturi</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="NL">
            <TI_CY>Duitsland</TI_CY>
            <TI_TOWN>Neuherberg</TI_TOWN>
            <TI_TEXT>
               <P>Algemene infectiewerende middelen voor systemisch gebruik, vaccins, antineoplastica en immunomodulerende middelen</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="PL">
            <TI_CY>Niemcy</TI_CY>
            <TI_TOWN>Neuherberg</TI_TOWN>
            <TI_TEXT>
               <P>Ogólne środki przeciwinfekcyjne do użytku ogólnoustrojowego, szczepionki, środki przeciwnowotworowe oraz immunomodulacyjne</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="PT">
            <TI_CY>Alemanha</TI_CY>
            <TI_TOWN>Neuherberg</TI_TOWN>
            <TI_TEXT>
               <P>Anti-infecciosos gerais de uso sistémico, vacinas, antineoplásicos e imunomoduladores</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="RO">
            <TI_CY>Germania</TI_CY>
            <TI_TOWN>Neuherberg</TI_TOWN>
            <TI_TEXT>
               <P>Antiinfecţioase generale pentru uz sistemic, vaccinuri, antineoplazice şi imunomodulatoare</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="SK">
            <TI_CY>Nemecko</TI_CY>
            <TI_TOWN>Neuherberg</TI_TOWN>
            <TI_TEXT>
               <P>Všeobecné antiinfekčné látky na systémové použitie, očkovacie látky, antineoplastické prostriedky a imunomodulačné činidlá</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="SL">
            <TI_CY>Nemčija</TI_CY>
            <TI_TOWN>Neuherberg</TI_TOWN>
            <TI_TEXT>
               <P>Antimikotiki za sistemsko zdravljenje, cepiva, zdravila z delovanjem na novotvorbe in imunomodulatorji</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="SV">
            <TI_CY>Tyskland</TI_CY>
            <TI_TOWN>Neuherberg</TI_TOWN>
            <TI_TEXT>
               <P>Antiinfektiva medel för systemiskt bruk, vacciner, cytostatika/cytotoxiska medel, samt immunmodulerande medel</P>
            </TI_TEXT>
         </ML_TI_DOC>
      </ML_TITLES>
      <ML_AA_NAMES>
         <AA_NAME LG="EN">Einkauf/Labor</AA_NAME>
      </ML_AA_NAMES>
   </TRANSLATION_SECTION>
   <FORM_SECTION>
      <F01_2014 CATEGORY="ORIGINAL" FORM="F01" LG="EN">
         <NOTICE TYPE="PRI_CALL_COMPETITION"/>
         <CONTRACTING_BODY>
            <ADDRESS_CONTRACTING_BODY>
               <OFFICIALNAME>Einkauf/Labor</OFFICIALNAME>
               <ADDRESS>Ingolstaedter Landstr. 1</ADDRESS>
               <TOWN>Oberschleissheim/Neuherberg</TOWN>
               <POSTAL_CODE>85767</POSTAL_CODE>
               <COUNTRY VALUE="DE"/>
               <CONTACT_POINT>Einkauf — Frau Lanzafame</CONTACT_POINT>
               <PHONE>+49 8931872735</PHONE>
               <E_MAIL>petra.lanzafame@helmholtz-muenchen.de</E_MAIL>
               <FAX>+49 8931873327</FAX>
               <n2016:NUTS CODE="DE21H"/>
               <URL_GENERAL>www.helmholtz-muenchen.de</URL_GENERAL>
            </ADDRESS_CONTRACTING_BODY>
            <CENTRAL_PURCHASING/>
            <ADDRESS_FURTHER_INFO_IDEM/>
            <ADDRESS_PARTICIPATION_IDEM/>
            <CA_TYPE VALUE="BODY_PUBLIC"/>
            <CA_ACTIVITY_OTHER>Research Center (Environmental Health)</CA_ACTIVITY_OTHER>
         </CONTRACTING_BODY>
         <OBJECT_CONTRACT ITEM="1">
            <TITLE>
               <P>Production of a VLP vaccine</P>
            </TITLE>
            <CPV_MAIN>
               <CPV_CODE CODE="33650000"/>
            </CPV_MAIN>
            <TYPE_CONTRACT CTYPE="SERVICES"/>
            <SHORT_DESCR>
               <P>Production of a recombinant virus-like particle (VLP) vaccine from HEK293 cells.</P>
            </SHORT_DESCR>
            <NO_LOT_DIVISION/>
            <OBJECT_DESCR ITEM="1">
               <n2016:NUTS CODE="DE21H"/>
               <SHORT_DESCR>
                  <P>Aims:</P>
                  <P>We are looking for a contract manufacturer (CMO) for preparatory project work towards GMP-compliant manufacture of a recombinant VLP derived from HEK293 cells. This vaccine will be explored as a prophylactic vaccine in clinical phase I/II studies.</P>
                  <P>Product description:</P>
                  <P>Recombinant HEK293 cells stably carrying a BACmid with the required elements of the viral genome. Production of VLPs is induced by transient transfection with a helper plasmid. The VLP product will be harvested from the cell culture supernatant and subsequently purified, concentrated and characterized.</P>
                  <P>Project start:</P>
                  <P>Fourth quarter 2018.</P>
                  <P>Manufacturer specifications of service:</P>
                  <P>The contract manufacturer has to comply with the following criteria regarding, expertise, experience, manufacturing process, quality control and product release.</P>
                  <P>— Long-time experience in the GMP-manufacture of recombinant viral vaccines and virus-like particles (proof by references),</P>
                  <P>— Experiences in the cultivation of HEK293 cells for both adherent and suspension and transient transfection of HEK293 with plasmid DNA in particular (please explain),</P>
                  <P>— State of the Art facilities and protocols for the manufacture of Investigational Medicinal Products (please explain),</P>
                  <P>— Equipment and processes for aseptic liquid filling, packaging and labeling within the GMP-facility (please explain),</P>
                  <P>— Equipment for generation and storage of eukaryotic cell banks (please confirm or explain),</P>
                  <P>— Extensive quality control (regarding purity, identity and safety) and product release. Additionally, adaptation and validation of ELISA and cell based analytical assays (please explain),</P>
                  <P>— EMA certified GMP facility (please copies of the certificates),</P>
                  <P>— Willingness to interact with the academic partner institutions on a regular basis over the course of the project (please confirm).</P>
               </SHORT_DESCR>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
         </OBJECT_CONTRACT>
         <PROCEDURE>
            <PT_COMPETITIVE_NEGOTIATION/>
            <CONTRACT_COVERED_GPA/>
            <DATE_RECEIPT_TENDERS>2018-04-13</DATE_RECEIPT_TENDERS>
            <TIME_RECEIPT_TENDERS>12:00</TIME_RECEIPT_TENDERS>
            <LANGUAGES>
               <LANGUAGE VALUE="EN"/>
               <LANGUAGE VALUE="DE"/>
            </LANGUAGES>
         </PROCEDURE>
         <COMPLEMENTARY_INFO>
            <INFO_ADD>
               <P>Please send your expression of interest at the latest (13.4.2018) under use of the reference nº 009-18 to: petra.lanzafame@helmholtz-muenchen.de</P>
            </INFO_ADD>
            <ADDRESS_REVIEW_BODY>
               <OFFICIALNAME>Vergabekammer des Bundes</OFFICIALNAME>
               <ADDRESS>Villemombler Str. 76</ADDRESS>
               <TOWN>Bonn</TOWN>
               <POSTAL_CODE>53123</POSTAL_CODE>
               <COUNTRY VALUE="DE"/>
            </ADDRESS_REVIEW_BODY>
            <DATE_DISPATCH_NOTICE>2018-03-12</DATE_DISPATCH_NOTICE>
         </COMPLEMENTARY_INFO>
      </F01_2014>
   </FORM_SECTION>
</TED_EXPORT>
